Relief Therapeutics Holding AG (0QKQ.L)
| Previous close | 0.0782 |
| Open | 0.0798 |
| Bid | 0.0000 x N/A |
| Ask | 0.0000 x N/A |
| Day's range | 0.0762 - 0.0802 |
| 52-week range | 0.0762 - 0.0802 |
| Volume | |
| Avg. volume | N/A |
| Market cap | 49.955M |
| Beta (5Y monthly) | -21.74 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.0100 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- EQS Group
Relief Reports US Collaboration Partner Announces Expansion of Aviptadil US Expanded Access & Right to Try Programs for Patients w/COVID-19 Respiratory Failure who've Exhausted All Approved Therapies
RELIEF THERAPEUTICS Holding AG / Key word(s): Miscellaneous19-Jan-2022 / 07:00 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Relief Reports that its U.S. Collaboration Partner has Announced Expansion of Aviptadil U.S. Expanded Access and Right to Try Programs for Patients With COVID-19 Respiratory Failure who Have Exhausted All Approved TherapiesGeneva, Switzerland, January 19, 2022 - RELIEF THERAPEUTICS Hold
- EQS Group
Relief Therapeutics Comments on NRx Pharmaceuticals' Press Release Reporting on its Recently Filed Lawsuit
RELIEF THERAPEUTICS Holding AG / Key word(s): Legal Matter14-Jan-2022 / 07:00 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Relief Therapeutics Comments on NRx Pharmaceuticals' Press Release Reporting on its Recently Filed Lawsuit Geneva, Switzerland, January 14, 2022 - RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTY) ("Relief"), a biopharmaceutical company seeking to provide patients therapeuti
- EQS Group
Relief Comments on Lawsuit Filed Against It by NeuroRx
RELIEF THERAPEUTICS Holding AG / Key word(s): Legal Matter12-Jan-2022 / 07:00 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Relief Comments on Lawsuit Filed Against It by NeuroRxGeneva, Switzerland, January 12, 2022 - RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTY) ("Relief"), a biopharmaceutical company seeking to provide patients therapeutic relief from serious diseases with high unmet need,
